GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Inventory-to-Revenue

Biolife Sciences (Biolife Sciences) Inventory-to-Revenue : 0.00 (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biolife Sciences's Average Total Inventories for the quarter that ended in May. 2008 was $0.00 Mil. Biolife Sciences's Revenue for the three months ended in May. 2008 was $1.80 Mil. Biolife Sciences's Inventory-to-Revenue for the quarter that ended in May. 2008 was 0.00.

Biolife Sciences's Inventory-to-Revenue for the quarter that ended in May. 2008 stayed the same from Feb. 2008 (0.00) to Feb. 2008 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Biolife Sciences's Days Inventory for the three months ended in May. 2008 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Biolife Sciences Inventory-to-Revenue Historical Data

The historical data trend for Biolife Sciences's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Inventory-to-Revenue Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Inventory-to-Revenue
- - - -

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biolife Sciences's Inventory-to-Revenue

For the Medical Instruments & Supplies subindustry, Biolife Sciences's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolife Sciences's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's Inventory-to-Revenue falls into.



Biolife Sciences Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biolife Sciences's Inventory-to-Revenue for the fiscal year that ended in Nov. 2007 is calculated as

Inventory-to-Revenue (A: Nov. 2007 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Nov. 2006 ) + Total Inventories (A: Nov. 2007 )) / count ) / Revenue (A: Nov. 2007 )
=( (0 + 0) / 1 ) / 8.603
=0 / 8.603
=0.00

Biolife Sciences's Inventory-to-Revenue for the quarter that ended in May. 2008 is calculated as

Inventory-to-Revenue (Q: May. 2008 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Feb. 2008 ) + Total Inventories (Q: May. 2008 )) / count ) / Revenue (Q: May. 2008 )
=( (0 + 0) / 1 ) / 1.798
=0 / 1.798
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biolife Sciences  (OTCPK:BLFE) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biolife Sciences's Days Inventory for the three months ended in May. 2008 is calculated as:

Days Inventory=Average Total Inventories (Q: May. 2008 )/Cost of Goods Sold (Q: May. 2008 )*Days in Period
=0/1.442*365 / 4
=0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Biolife Sciences's Inventory Turnover for the quarter that ended in May. 2008 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: May. 2008 ) / Average Total Inventories (Q: May. 2008 )
=1.442 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biolife Sciences Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020